At close: December 13 at 4:00:01 PM EST
After hours: December 13 at 5:00:16 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | 65.3M | -- |
| Sales Growth (year/est) | -- | -- | -100.00% | -- |
Earnings History
| Currency in USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.79 | -1.27 | -1.26 | -1.4 |
| EPS Actual | 8.46 | -1.66 | -1.37 | -1.13 |
| Difference | 10.26 | -0.39 | -0.11 | 0.27 |
| Surprise % | 571.31% | -30.71% | -8.73% | 19.56% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MEIP | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Downgrade | Laidlaw & Co.: Buy to Hold | 7/23/2024 |
| Maintains | Stifel: Hold to Hold | 4/12/2024 |
| Maintains | Stifel: Hold to Hold | 2/14/2024 |
| Maintains | Stifel: Hold to Hold | 9/27/2023 |
| Maintains | Brookline Capital: Buy to Buy | 5/23/2023 |
| Maintains | Stifel: Hold to Hold | 5/12/2023 |
Related Tickers
PIRS Pieris Pharmaceuticals, Inc.
13.60
-15.58%
ANTX AN2 Therapeutics, Inc.
1.4300
-3.38%
ELVN Enliven Therapeutics, Inc.
23.15
+0.65%
SLNO Soleno Therapeutics, Inc.
46.71
+0.93%
17R.BE Travere Therapeutics Inc
16.40
-4.65%
TRRI Alzex Neuropharma Inc.
0.2400
0.00%
PMCB PharmaCyte Biotech, Inc.
1.7200
+2.99%
HTDS Hard to Treat Diseases Inc.
0.0000
0.00%
TRAW Traws Pharma, Inc.
4.6501
-9.00%
CRIS Curis, Inc.
3.5700
-4.03%